Logo

BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 401k Plan overview

Plan NameBIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN
Plan identification number 001

BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Participant-directed brokerage accounts provided as an investment option under the plan.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

BIOMARIN PHARMACEUTICAL INC. has sponsored the creation of one or more 401k plans.

Company Name:BIOMARIN PHARMACEUTICAL INC.
Employer identification number (EIN):680397820
NAIC Classification:325410

Form 5500 Filing Information

Submission information for form 5500 for 401k plan BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012024-01-01AMY WIREMAN
0012023-01-01
0012023-01-01AMY WIREMAN
0012022-01-01
0012022-01-01AMY WIREMAN
0012021-01-01
0012021-01-01AMY WIREMAN
0012020-01-01
0012019-01-01
0012017-01-01AMY WIREMAN
0012016-01-01RICHARD RANIERI
0012015-01-01RICHARD RANIERI
0012014-01-01RICHARD RANIERI
0012013-01-01RICHARD RANIERI
0012012-01-01ERIC DAVIS ERIC DAVIS2013-10-14
0012011-01-01MARK WOOD MARK WOOD2012-10-05
0012009-01-01MARK WOOD
0012008-01-01

Plan Statistics for BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN

401k plan membership statisitcs for BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN

Measure Date Value
2023: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2023 401k membership
Total participants, beginning-of-year2023-01-013,178
Total number of active participants reported on line 7a of the Form 55002023-01-012,309
Number of retired or separated participants receiving benefits2023-01-010
Number of other retired or separated participants entitled to future benefits2023-01-011,125
Total of all active and inactive participants2023-01-013,434
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2023-01-0114
Total participants2023-01-013,448
Number of participants with account balances2023-01-013,377
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2023-01-010
2022: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-013,054
Total number of active participants reported on line 7a of the Form 55002022-01-012,075
Number of retired or separated participants receiving benefits2022-01-010
Number of other retired or separated participants entitled to future benefits2022-01-011,098
Total of all active and inactive participants2022-01-013,173
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-015
Total participants2022-01-013,178
Number of participants with account balances2022-01-013,119
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-010
2021: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-012,943
Total number of active participants reported on line 7a of the Form 55002021-01-012,124
Number of retired or separated participants receiving benefits2021-01-010
Number of other retired or separated participants entitled to future benefits2021-01-01924
Total of all active and inactive participants2021-01-013,048
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-016
Total participants2021-01-013,054
Number of participants with account balances2021-01-012,985
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-010
2020: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-012,831
Total number of active participants reported on line 7a of the Form 55002020-01-012,201
Number of retired or separated participants receiving benefits2020-01-010
Number of other retired or separated participants entitled to future benefits2020-01-01737
Total of all active and inactive participants2020-01-012,938
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-015
Total participants2020-01-012,943
Number of participants with account balances2020-01-012,901
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-010
2019: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-012,593
Total number of active participants reported on line 7a of the Form 55002019-01-012,170
Number of retired or separated participants receiving benefits2019-01-010
Number of other retired or separated participants entitled to future benefits2019-01-01657
Total of all active and inactive participants2019-01-012,827
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-014
Total participants2019-01-012,831
Number of participants with account balances2019-01-012,769
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-010
2017: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-012,087
Total number of active participants reported on line 7a of the Form 55002017-01-011,933
Number of retired or separated participants receiving benefits2017-01-010
Number of other retired or separated participants entitled to future benefits2017-01-01420
Total of all active and inactive participants2017-01-012,353
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-012
Total participants2017-01-012,355
Number of participants with account balances2017-01-012,301
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-012
2016: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-011,889
Total number of active participants reported on line 7a of the Form 55002016-01-011,709
Number of retired or separated participants receiving benefits2016-01-010
Number of other retired or separated participants entitled to future benefits2016-01-01374
Total of all active and inactive participants2016-01-012,083
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-014
Total participants2016-01-012,087
Number of participants with account balances2016-01-012,032
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-013
2015: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-011,538
Total number of active participants reported on line 7a of the Form 55002015-01-011,615
Number of retired or separated participants receiving benefits2015-01-010
Number of other retired or separated participants entitled to future benefits2015-01-01272
Total of all active and inactive participants2015-01-011,887
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-012
Total participants2015-01-011,889
Number of participants with account balances2015-01-011,819
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-010
2014: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-011,337
Total number of active participants reported on line 7a of the Form 55002014-01-011,319
Number of retired or separated participants receiving benefits2014-01-010
Number of other retired or separated participants entitled to future benefits2014-01-01218
Total of all active and inactive participants2014-01-011,537
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-011
Total participants2014-01-011,538
Number of participants with account balances2014-01-011,497
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-0141
2013: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-011,119
Total number of active participants reported on line 7a of the Form 55002013-01-011,163
Number of retired or separated participants receiving benefits2013-01-010
Number of other retired or separated participants entitled to future benefits2013-01-01172
Total of all active and inactive participants2013-01-011,335
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-012
Total participants2013-01-011,337
Number of participants with account balances2013-01-011,293
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-0159
2012: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-01986
Total number of active participants reported on line 7a of the Form 55002012-01-01977
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-01142
Total of all active and inactive participants2012-01-011,119
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-010
Total participants2012-01-011,119
Number of participants with account balances2012-01-011,075
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-0149
2011: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-01835
Total number of active participants reported on line 7a of the Form 55002011-01-01862
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-01124
Total of all active and inactive participants2011-01-01986
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01986
Number of participants with account balances2011-01-01959
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-0140
2009: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-01679
Total number of active participants reported on line 7a of the Form 55002009-01-01644
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-01101
Total of all active and inactive participants2009-01-01745
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01745
Number of participants with account balances2009-01-01719
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-0128

Financial Data on BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN

Measure Date Value
2023 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2023 401k financial data
Total income from all sources (including contributions)2023-12-31$168,724,694
Total of all expenses incurred2023-12-31$46,292,401
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-12-31$46,202,156
Value of total corrective distributions2023-12-31$39,960
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-12-31$66,898,064
Value of total assets at end of year2023-12-31$616,847,325
Value of total assets at beginning of year2023-12-31$494,415,032
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-12-31$50,285
Total interest from all sources2023-12-31$243,798
Total dividends received (eg from common stock, registered investment company shares)2023-12-31$7,352,545
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2023-12-31$7,352,545
Was this plan covered by a fidelity bond2023-12-31Yes
Value of fidelity bond cover2023-12-31$5,000,000
If this is an individual account plan, was there a blackout period2023-12-31No
Were there any nonexempt tranactions with any party-in-interest2023-12-31No
Contributions received from participants2023-12-31$36,647,661
Participant contributions at end of year2023-12-31$4,543,133
Participant contributions at beginning of year2023-12-31$4,423,059
Assets. Other investments not covered elsewhere at end of year2023-12-31$24,287,256
Assets. Other investments not covered elsewhere at beginning of year2023-12-31$18,605,551
Income. Received or receivable in cash from other sources (including rollovers)2023-12-31$5,333,904
Other income not declared elsewhere2023-12-31$5,026,556
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Value of net income/loss2023-12-31$122,432,293
Value of net assets at end of year (total assets less liabilities)2023-12-31$616,847,325
Value of net assets at beginning of year (total assets less liabilities)2023-12-31$494,415,032
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2023-12-31No
Were any leases to which the plan was party in default or uncollectible2023-12-31No
Investment advisory and management fees2023-12-31$43,385
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-12-31$296,764,217
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-12-31$242,741,737
Interest on participant loans2023-12-31$241,665
Value of interest in common/collective trusts at end of year2023-12-31$288,345,688
Value of interest in common/collective trusts at beginning of year2023-12-31$226,377,373
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2023-12-31$618,554
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2023-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2023-12-31$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2023-12-31$2,133
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-12-31$48,266,996
Net investment gain or loss from common/collective trusts2023-12-31$40,936,735
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-12-31No
Was there a failure to transmit to the plan any participant contributions2023-12-31No
Has the plan failed to provide any benefit when due under the plan2023-12-31No
Contributions received in cash from employer2023-12-31$24,916,499
Employer contributions (assets) at end of year2023-12-31$2,288,477
Employer contributions (assets) at beginning of year2023-12-31$2,267,312
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-12-31$46,202,156
Did the plan have assets held for investment2023-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-12-31No
Opinion of an independent qualified public accountant for this plan2023-12-31Unqualified
Accountancy firm name2023-12-31MOSS ADAMS LLP
Accountancy firm EIN2023-12-31910189318
Total income from all sources (including contributions)2023-01-01$168,724,694
Total of all expenses incurred2023-01-01$46,292,401
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-01-01$46,202,156
Value of total corrective distributions2023-01-01$39,960
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-01-01$66,898,064
Value of total assets at end of year2023-01-01$616,847,325
Value of total assets at beginning of year2023-01-01$494,415,032
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-01-01$50,285
Total interest from all sources2023-01-01$243,798
Total dividends received (eg from common stock, registered investment company shares)2023-01-01$7,352,545
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-01-01No
Total dividends received from registered investment company shares (eg mutual funds)2023-01-01$7,352,545
Was this plan covered by a fidelity bond2023-01-01Yes
Value of fidelity bond cover2023-01-01$5,000,000
If this is an individual account plan, was there a blackout period2023-01-01No
Were there any nonexempt tranactions with any party-in-interest2023-01-01No
Contributions received from participants2023-01-01$36,647,661
Participant contributions at end of year2023-01-01$4,543,133
Participant contributions at beginning of year2023-01-01$4,423,059
Assets. Other investments not covered elsewhere at end of year2023-01-01$24,287,256
Assets. Other investments not covered elsewhere at beginning of year2023-01-01$18,605,551
Income. Received or receivable in cash from other sources (including rollovers)2023-01-01$5,333,904
Other income not declared elsewhere2023-01-01$5,026,556
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-01-01No
Value of net income/loss2023-01-01$122,432,293
Value of net assets at end of year (total assets less liabilities)2023-01-01$616,847,325
Value of net assets at beginning of year (total assets less liabilities)2023-01-01$494,415,032
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-01-01No
Were any loans by the plan or fixed income obligations due to the plan in default2023-01-01No
Were any leases to which the plan was party in default or uncollectible2023-01-01No
Investment advisory and management fees2023-01-01$43,385
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-01-01$296,764,217
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-01-01$242,741,737
Interest on participant loans2023-01-01$241,665
Value of interest in common/collective trusts at end of year2023-01-01$288,345,688
Value of interest in common/collective trusts at beginning of year2023-01-01$226,377,373
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2023-01-01$618,554
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2023-01-01$2,133
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-01-01$48,266,996
Net investment gain or loss from common/collective trusts2023-01-01$40,936,735
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-01-01No
Was there a failure to transmit to the plan any participant contributions2023-01-01No
Has the plan failed to provide any benefit when due under the plan2023-01-01No
Contributions received in cash from employer2023-01-01$24,916,499
Employer contributions (assets) at end of year2023-01-01$2,288,477
Employer contributions (assets) at beginning of year2023-01-01$2,267,312
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-01-01$46,202,156
Did the plan have assets held for investment2023-01-01Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-01-01No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-01-01No
Opinion of an independent qualified public accountant for this plan2023-01-011
Accountancy firm name2023-01-01MOSS ADAMS LLP
Accountancy firm EIN2023-01-01910189318
2022 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total income from all sources (including contributions)2022-12-31$-46,213,978
Total loss/gain on sale of assets2022-12-31$0
Total of all expenses incurred2022-12-31$27,636,023
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$27,556,289
Value of total corrective distributions2022-12-31$29,127
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$60,200,139
Value of total assets at end of year2022-12-31$494,415,032
Value of total assets at beginning of year2022-12-31$568,265,033
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$50,607
Total interest from all sources2022-12-31$204,376
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$8,441,142
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$8,441,142
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$5,000,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$34,273,138
Participant contributions at end of year2022-12-31$4,423,059
Participant contributions at beginning of year2022-12-31$4,664,810
Assets. Other investments not covered elsewhere at end of year2022-12-31$18,605,551
Assets. Other investments not covered elsewhere at beginning of year2022-12-31$22,526,336
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$2,499,590
Other income not declared elsewhere2022-12-31$-6,080,977
Administrative expenses (other) incurred2022-12-31$5,050
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-73,850,001
Value of net assets at end of year (total assets less liabilities)2022-12-31$494,415,032
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$568,265,033
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Investment advisory and management fees2022-12-31$45,557
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$242,741,737
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$293,465,004
Interest on participant loans2022-12-31$204,376
Value of interest in common/collective trusts at end of year2022-12-31$226,377,373
Value of interest in common/collective trusts at beginning of year2022-12-31$245,540,791
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-70,494,460
Net investment gain or loss from common/collective trusts2022-12-31$-38,484,198
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$23,427,411
Employer contributions (assets) at end of year2022-12-31$2,267,312
Employer contributions (assets) at beginning of year2022-12-31$2,068,092
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$27,556,289
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31MOSS ADAMS LLP
Accountancy firm EIN2022-12-31910189318
Total unrealized appreciation/depreciation of assets2022-01-01$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-01-01$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-01-01$0
Total income from all sources (including contributions)2022-01-01$-46,213,978
Total loss/gain on sale of assets2022-01-01$0
Total of all expenses incurred2022-01-01$27,636,023
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-01-01$27,556,289
Value of total corrective distributions2022-01-01$29,127
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-01-01$60,200,139
Value of total assets at end of year2022-01-01$494,415,032
Value of total assets at beginning of year2022-01-01$568,265,033
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-01-01$50,607
Total interest from all sources2022-01-01$204,376
Total dividends received (eg from common stock, registered investment company shares)2022-01-01$8,441,142
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-01-01No
Total dividends received from registered investment company shares (eg mutual funds)2022-01-01$8,441,142
Was this plan covered by a fidelity bond2022-01-01Yes
Value of fidelity bond cover2022-01-01$5,000,000
If this is an individual account plan, was there a blackout period2022-01-01No
Were there any nonexempt tranactions with any party-in-interest2022-01-01No
Contributions received from participants2022-01-01$34,273,138
Participant contributions at end of year2022-01-01$4,423,059
Participant contributions at beginning of year2022-01-01$4,664,810
Assets. Other investments not covered elsewhere at end of year2022-01-01$18,605,551
Assets. Other investments not covered elsewhere at beginning of year2022-01-01$22,526,336
Income. Received or receivable in cash from other sources (including rollovers)2022-01-01$2,499,590
Other income not declared elsewhere2022-01-01$-6,080,977
Administrative expenses (other) incurred2022-01-01$5,050
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-01-01No
Value of net income/loss2022-01-01$-73,850,001
Value of net assets at end of year (total assets less liabilities)2022-01-01$494,415,032
Value of net assets at beginning of year (total assets less liabilities)2022-01-01$568,265,033
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-01-01No
Were any loans by the plan or fixed income obligations due to the plan in default2022-01-01No
Were any leases to which the plan was party in default or uncollectible2022-01-01No
Investment advisory and management fees2022-01-01$45,557
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-01-01$242,741,737
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-01-01$293,465,004
Interest on participant loans2022-01-01$204,376
Value of interest in common/collective trusts at end of year2022-01-01$226,377,373
Value of interest in common/collective trusts at beginning of year2022-01-01$245,540,791
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-01-01$-70,494,460
Net investment gain or loss from common/collective trusts2022-01-01$-38,484,198
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-01-01No
Was there a failure to transmit to the plan any participant contributions2022-01-01No
Has the plan failed to provide any benefit when due under the plan2022-01-01No
Contributions received in cash from employer2022-01-01$23,427,411
Employer contributions (assets) at end of year2022-01-01$2,267,312
Employer contributions (assets) at beginning of year2022-01-01$2,068,092
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-01-01$27,556,289
Did the plan have assets held for investment2022-01-01Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-01-01No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-01-01No
Opinion of an independent qualified public accountant for this plan2022-01-011
Accountancy firm name2022-01-01MOSS ADAMS LLP
Accountancy firm EIN2022-01-01910189318
2021 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$133,748,617
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$28,544,141
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$28,415,736
Expenses. Certain deemed distributions of participant loans2021-12-31$21,445
Value of total corrective distributions2021-12-31$52,955
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$58,361,202
Value of total assets at end of year2021-12-31$568,265,033
Value of total assets at beginning of year2021-12-31$463,060,557
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$54,005
Total interest from all sources2021-12-31$196,021
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$14,613,117
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$14,613,117
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$5,000,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$32,492,793
Participant contributions at end of year2021-12-31$4,664,810
Participant contributions at beginning of year2021-12-31$3,759,519
Assets. Other investments not covered elsewhere at end of year2021-12-31$22,526,336
Assets. Other investments not covered elsewhere at beginning of year2021-12-31$14,353,103
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$3,977,033
Other income not declared elsewhere2021-12-31$1,904,134
Administrative expenses (other) incurred2021-12-31$8,300
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$105,204,476
Value of net assets at end of year (total assets less liabilities)2021-12-31$568,265,033
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$463,060,557
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Investment advisory and management fees2021-12-31$45,705
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$293,465,004
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$239,826,846
Interest on participant loans2021-12-31$196,021
Value of interest in common/collective trusts at end of year2021-12-31$245,540,791
Value of interest in common/collective trusts at beginning of year2021-12-31$202,580,288
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$31,232,257
Net investment gain or loss from common/collective trusts2021-12-31$27,441,886
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$21,891,376
Employer contributions (assets) at end of year2021-12-31$2,068,092
Employer contributions (assets) at beginning of year2021-12-31$2,540,801
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$28,415,736
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31MOSS ADAMS LLP
Accountancy firm EIN2021-12-31910189318
2020 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$126,615,626
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$19,427,287
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$19,387,475
Value of total corrective distributions2020-12-31$21,135
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$62,054,778
Value of total assets at end of year2020-12-31$463,060,557
Value of total assets at beginning of year2020-12-31$355,872,218
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$18,677
Total interest from all sources2020-12-31$197,251
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$7,272,256
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$7,272,256
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$5,000,000
If this is an individual account plan, was there a blackout period2020-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2020-12-31$0
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$32,281,129
Participant contributions at end of year2020-12-31$3,759,519
Participant contributions at beginning of year2020-12-31$3,629,676
Assets. Other investments not covered elsewhere at end of year2020-12-31$14,353,103
Assets. Other investments not covered elsewhere at beginning of year2020-12-31$6,696,938
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$6,876,129
Other income not declared elsewhere2020-12-31$2,689,219
Administrative expenses (other) incurred2020-12-31$3,100
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$107,188,339
Value of net assets at end of year (total assets less liabilities)2020-12-31$463,060,557
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$355,872,218
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Investment advisory and management fees2020-12-31$15,577
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$239,826,846
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$190,769,657
Interest on participant loans2020-12-31$197,251
Value of interest in common/collective trusts at end of year2020-12-31$202,580,288
Value of interest in common/collective trusts at beginning of year2020-12-31$154,775,947
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$30,235,072
Net investment gain or loss from common/collective trusts2020-12-31$24,167,050
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$22,897,520
Employer contributions (assets) at end of year2020-12-31$2,540,801
Employer contributions (assets) at beginning of year2020-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$19,387,475
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Unqualified
Accountancy firm name2020-12-31MOSS ADAMS LLP
Accountancy firm EIN2020-12-31910189318
2019 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$116,667,768
Total income from all sources (including contributions)2019-12-31$116,667,768
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$17,176,456
Total of all expenses incurred2019-12-31$17,176,456
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$17,159,827
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$17,159,827
Value of total corrective distributions2019-12-31$490
Value of total corrective distributions2019-12-31$490
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$52,209,780
Value of total assets at end of year2019-12-31$355,872,218
Value of total assets at end of year2019-12-31$355,872,218
Value of total assets at beginning of year2019-12-31$256,380,906
Value of total assets at beginning of year2019-12-31$256,380,906
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$16,139
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$16,139
Total interest from all sources2019-12-31$179,801
Total interest from all sources2019-12-31$179,801
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$5,486,782
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$5,486,782
Was this plan covered by a fidelity bond2019-12-31Yes
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$5,000,000
Value of fidelity bond cover2019-12-31$5,000,000
If this is an individual account plan, was there a blackout period2019-12-31No
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$28,781,780
Contributions received from participants2019-12-31$28,781,780
Participant contributions at end of year2019-12-31$3,629,676
Participant contributions at end of year2019-12-31$3,629,676
Participant contributions at beginning of year2019-12-31$3,232,362
Participant contributions at beginning of year2019-12-31$3,232,362
Assets. Other investments not covered elsewhere at end of year2019-12-31$6,696,938
Assets. Other investments not covered elsewhere at end of year2019-12-31$6,696,938
Assets. Other investments not covered elsewhere at beginning of year2019-12-31$4,243,266
Assets. Other investments not covered elsewhere at beginning of year2019-12-31$4,243,266
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$3,579,137
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$3,579,137
Other income not declared elsewhere2019-12-31$928,292
Administrative expenses (other) incurred2019-12-31$6,300
Administrative expenses (other) incurred2019-12-31$6,300
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$99,491,312
Value of net income/loss2019-12-31$99,491,312
Value of net assets at end of year (total assets less liabilities)2019-12-31$355,872,218
Value of net assets at end of year (total assets less liabilities)2019-12-31$355,872,218
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$256,380,906
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$256,380,906
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Investment advisory and management fees2019-12-31$9,839
Investment advisory and management fees2019-12-31$9,839
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$190,769,657
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$190,769,657
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$140,994,340
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$140,994,340
Interest earned on other investments2019-12-31$179,801
Interest earned on other investments2019-12-31$179,801
Value of interest in common/collective trusts at end of year2019-12-31$154,775,947
Value of interest in common/collective trusts at end of year2019-12-31$154,775,947
Value of interest in common/collective trusts at beginning of year2019-12-31$107,910,938
Value of interest in common/collective trusts at beginning of year2019-12-31$107,910,938
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$34,351,519
Net investment gain or loss from common/collective trusts2019-12-31$23,511,594
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$19,848,863
Contributions received in cash from employer2019-12-31$19,848,863
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$17,159,827
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$17,159,827
Did the plan have assets held for investment2019-12-31Yes
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31MOSS ADAMS LLP
Accountancy firm name2019-12-31MOSS ADAMS LLP
Accountancy firm EIN2019-12-31910189318
Accountancy firm EIN2019-12-31910189318
2018 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$29,845,016
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$12,455,554
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$12,439,602
Value of total corrective distributions2018-12-31$1,386
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$46,172,159
Value of total assets at end of year2018-12-31$256,380,906
Value of total assets at beginning of year2018-12-31$238,991,444
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$14,566
Total interest from all sources2018-12-31$129,608
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$4,562,414
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$4,562,414
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$5,000,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$25,503,438
Participant contributions at end of year2018-12-31$3,232,362
Participant contributions at beginning of year2018-12-31$2,561,069
Participant contributions at end of year2018-12-31$0
Participant contributions at beginning of year2018-12-31$947
Assets. Other investments not covered elsewhere at end of year2018-12-31$4,243,266
Assets. Other investments not covered elsewhere at beginning of year2018-12-31$3,890,428
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$2,991,797
Other income not declared elsewhere2018-12-31$-491,505
Administrative expenses (other) incurred2018-12-31$7,728
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$17,389,462
Value of net assets at end of year (total assets less liabilities)2018-12-31$256,380,906
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$238,991,444
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Investment advisory and management fees2018-12-31$6,838
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$140,994,340
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$138,766,869
Interest on participant loans2018-12-31$129,608
Value of interest in common/collective trusts at end of year2018-12-31$107,910,938
Value of interest in common/collective trusts at beginning of year2018-12-31$93,771,657
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-14,640,903
Net investment gain or loss from common/collective trusts2018-12-31$-5,886,757
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31Yes
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$17,676,924
Employer contributions (assets) at end of year2018-12-31$0
Employer contributions (assets) at beginning of year2018-12-31$474
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$12,439,602
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31MOSS ADAMS LLP
Accountancy firm EIN2018-12-31910189318
2017 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$74,849,862
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$12,344,743
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$12,191,445
Value of total corrective distributions2017-12-31$13,578
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$40,485,404
Value of total assets at end of year2017-12-31$238,991,444
Value of total assets at beginning of year2017-12-31$176,486,325
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$139,720
Total interest from all sources2017-12-31$88,688
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$4,930,607
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$4,930,607
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$5,000,000
If this is an individual account plan, was there a blackout period2017-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$22,121,323
Participant contributions at end of year2017-12-31$2,561,069
Participant contributions at beginning of year2017-12-31$1,907,858
Participant contributions at end of year2017-12-31$947
Participant contributions at beginning of year2017-12-31$0
Assets. Other investments not covered elsewhere at end of year2017-12-31$3,890,428
Assets. Other investments not covered elsewhere at beginning of year2017-12-31$3,084,142
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$3,500,218
Other income not declared elsewhere2017-12-31$382,969
Administrative expenses (other) incurred2017-12-31$130,478
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$62,505,119
Value of net assets at end of year (total assets less liabilities)2017-12-31$238,991,444
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$176,486,325
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Investment advisory and management fees2017-12-31$9,242
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$138,766,869
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$104,118,698
Interest on participant loans2017-12-31$88,688
Value of interest in common/collective trusts at end of year2017-12-31$93,771,657
Value of interest in common/collective trusts at beginning of year2017-12-31$67,375,627
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$17,284,602
Net investment gain or loss from common/collective trusts2017-12-31$11,677,592
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$14,863,863
Employer contributions (assets) at end of year2017-12-31$474
Employer contributions (assets) at beginning of year2017-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$12,191,445
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31MOSS ADAMS LLP
Accountancy firm EIN2017-12-31910189318
2016 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$46,872,925
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$6,270,791
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$6,228,469
Value of total corrective distributions2016-12-31$14,607
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$34,527,481
Value of total assets at end of year2016-12-31$176,486,325
Value of total assets at beginning of year2016-12-31$135,884,191
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$27,715
Total interest from all sources2016-12-31$69,435
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$2,358,077
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$2,358,077
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$5,000,000
If this is an individual account plan, was there a blackout period2016-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2016-12-31$0
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$19,995,622
Participant contributions at end of year2016-12-31$1,907,858
Participant contributions at beginning of year2016-12-31$1,611,087
Assets. Other investments not covered elsewhere at end of year2016-12-31$3,084,142
Assets. Other investments not covered elsewhere at beginning of year2016-12-31$2,273,393
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$1,788,561
Other income not declared elsewhere2016-12-31$36,708
Administrative expenses (other) incurred2016-12-31$21,044
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$40,602,134
Value of net assets at end of year (total assets less liabilities)2016-12-31$176,486,325
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$135,884,191
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Investment advisory and management fees2016-12-31$6,671
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$104,118,698
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$83,525,152
Interest on participant loans2016-12-31$69,435
Value of interest in common/collective trusts at end of year2016-12-31$67,375,627
Value of interest in common/collective trusts at beginning of year2016-12-31$48,474,559
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$5,781,297
Net investment gain or loss from common/collective trusts2016-12-31$4,099,927
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$12,743,298
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$6,228,469
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31MOSS ADAMS LLP
Accountancy firm EIN2016-12-31910189318
2015 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$29,911,946
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$7,077,387
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$7,020,665
Value of total corrective distributions2015-12-31$27,406
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$30,193,961
Value of total assets at end of year2015-12-31$135,884,191
Value of total assets at beginning of year2015-12-31$113,049,632
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$29,316
Total interest from all sources2015-12-31$49,420
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$6,686,038
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$6,686,038
Administrative expenses professional fees incurred2015-12-31$21,525
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$5,000,000
If this is an individual account plan, was there a blackout period2015-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2015-12-31$0
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$16,782,986
Participant contributions at end of year2015-12-31$1,611,087
Participant contributions at beginning of year2015-12-31$1,154,835
Assets. Other investments not covered elsewhere at end of year2015-12-31$2,273,393
Assets. Other investments not covered elsewhere at beginning of year2015-12-31$1,180,157
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$2,983,832
Other income not declared elsewhere2015-12-31$-24,800
Administrative expenses (other) incurred2015-12-31$4,091
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Income. Non cash contributions2015-12-31$0
Value of net income/loss2015-12-31$22,834,559
Value of net assets at end of year (total assets less liabilities)2015-12-31$135,884,191
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$113,049,632
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Investment advisory and management fees2015-12-31$3,700
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$83,525,152
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$72,224,367
Interest on participant loans2015-12-31$49,420
Income. Interest from loans (other than to participants)2015-12-31$0
Interest earned on other investments2015-12-31$0
Income. Interest from US Government securities2015-12-31$0
Income. Interest from corporate debt instruments2015-12-31$0
Value of interest in common/collective trusts at end of year2015-12-31$48,474,559
Value of interest in common/collective trusts at beginning of year2015-12-31$38,490,273
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2015-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-6,763,207
Net investment gain or loss from common/collective trusts2015-12-31$-229,466
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31Yes
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$10,427,143
Income. Dividends from preferred stock2015-12-31$0
Income. Dividends from common stock2015-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$7,020,665
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31MOSS ADAMS LLP
Accountancy firm EIN2015-12-31910189318
2014 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$30,903,155
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$7,658,944
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$7,644,363
Value of total corrective distributions2014-12-31$6,682
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$24,000,751
Value of total assets at end of year2014-12-31$113,049,632
Value of total assets at beginning of year2014-12-31$89,805,421
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$7,899
Total interest from all sources2014-12-31$45,069
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$4,860,538
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$4,860,538
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$5,000,000
If this is an individual account plan, was there a blackout period2014-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2014-12-31$0
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$13,151,597
Participant contributions at end of year2014-12-31$1,154,835
Participant contributions at beginning of year2014-12-31$1,073,577
Assets. Other investments not covered elsewhere at end of year2014-12-31$1,180,157
Assets. Other investments not covered elsewhere at beginning of year2014-12-31$1,225,763
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$4,259,507
Other income not declared elsewhere2014-12-31$26,525
Administrative expenses (other) incurred2014-12-31$4,281
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$23,244,211
Value of net assets at end of year (total assets less liabilities)2014-12-31$113,049,632
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$89,805,421
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Investment advisory and management fees2014-12-31$3,618
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$72,224,367
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$57,486,738
Interest on participant loans2014-12-31$45,069
Value of interest in common/collective trusts at end of year2014-12-31$38,490,273
Value of interest in common/collective trusts at beginning of year2014-12-31$30,019,343
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$174,760
Net investment gain or loss from common/collective trusts2014-12-31$1,795,512
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$6,589,647
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$7,644,363
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31MOSS ADAMS LLP
Accountancy firm EIN2014-12-31910189318
2013 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$30,390,171
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$4,773,032
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$4,742,251
Value of total corrective distributions2013-12-31$1,423
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$14,656,845
Value of total assets at end of year2013-12-31$89,805,421
Value of total assets at beginning of year2013-12-31$64,188,282
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$29,358
Total interest from all sources2013-12-31$35,363
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$2,248,879
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$2,248,879
Assets. Real estate other than employer real property at end of year2013-12-31$0
Assets. Real estate other than employer real property at beginning of year2013-12-31$0
Administrative expenses professional fees incurred2013-12-31$19,425
Assets. Corporate prefeered stocks other than exployer securities at end of year2013-12-31$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year2013-12-31$0
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$5,000,000
If this is an individual account plan, was there a blackout period2013-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$10,209,023
Participant contributions at end of year2013-12-31$1,073,577
Participant contributions at beginning of year2013-12-31$773,246
Participant contributions at end of year2013-12-31$0
Participant contributions at beginning of year2013-12-31$0
Assets. Other investments not covered elsewhere at end of year2013-12-31$1,225,763
Assets. Other investments not covered elsewhere at beginning of year2013-12-31$1,095,687
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$1,943,585
Other income not declared elsewhere2013-12-31$111,847
Administrative expenses (other) incurred2013-12-31$3,900
Total non interest bearing cash at end of year2013-12-31$0
Total non interest bearing cash at beginning of year2013-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$25,617,139
Value of net assets at end of year (total assets less liabilities)2013-12-31$89,805,421
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$64,188,282
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Assets. partnership/joint venture interests at end of year2013-12-31$0
Assets. partnership/joint venture interests at beginning of year2013-12-31$0
Investment advisory and management fees2013-12-31$6,033
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$57,486,738
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$39,590,763
Value of interest in pooled separate accounts at end of year2013-12-31$0
Value of interest in pooled separate accounts at beginning of year2013-12-31$0
Interest on participant loans2013-12-31$35,363
Value of interest in common/collective trusts at end of year2013-12-31$30,019,343
Value of interest in common/collective trusts at beginning of year2013-12-31$22,728,586
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2013-12-31$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2013-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2013-12-31$0
Expenses. Payments to insurance carriers foe the provision of benefits2013-12-31$0
Asset value of US Government securities at end of year2013-12-31$0
Asset value of US Government securities at beginning of year2013-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$9,622,390
Net investment gain or loss from common/collective trusts2013-12-31$3,714,847
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$2,504,237
Employer contributions (assets) at end of year2013-12-31$0
Employer contributions (assets) at beginning of year2013-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$4,742,251
Assets. Corporate common stocks other than exployer securities at end of year2013-12-31$0
Assets. Corporate common stocks other than exployer securities at beginning of year2013-12-31$0
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31MOSS ADAMS LLP
Accountancy firm EIN2013-12-31910189318
2012 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$18,799,333
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$2,252,731
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$2,236,144
Value of total corrective distributions2012-12-31$1,401
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$11,666,423
Value of total assets at end of year2012-12-31$64,188,282
Value of total assets at beginning of year2012-12-31$47,641,680
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$15,186
Total interest from all sources2012-12-31$26,410
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$873,841
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2012-12-31$873,841
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$5,000,000
If this is an individual account plan, was there a blackout period2012-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2012-12-31$0
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$8,343,298
Participant contributions at end of year2012-12-31$773,246
Participant contributions at beginning of year2012-12-31$551,189
Assets. Other investments not covered elsewhere at end of year2012-12-31$1,095,687
Assets. Other investments not covered elsewhere at beginning of year2012-12-31$694,119
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$1,257,154
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2012-12-31$8,793
Other income not declared elsewhere2012-12-31$110,001
Administrative expenses (other) incurred2012-12-31$2,251
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$16,546,602
Value of net assets at end of year (total assets less liabilities)2012-12-31$64,188,282
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$47,641,680
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Investment advisory and management fees2012-12-31$12,935
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$39,590,763
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$30,260,447
Interest on participant loans2012-12-31$26,410
Value of interest in common/collective trusts at end of year2012-12-31$22,728,586
Value of interest in common/collective trusts at beginning of year2012-12-31$16,126,696
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$4,297,303
Net investment gain or loss from common/collective trusts2012-12-31$1,825,355
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$2,065,971
Employer contributions (assets) at beginning of year2012-12-31$436
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$2,236,144
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31MOSS ADAMS LLP
Accountancy firm EIN2012-12-31910189318
2011 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets2011-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total income from all sources (including contributions)2011-12-31$8,389,153
Total loss/gain on sale of assets2011-12-31$0
Total of all expenses incurred2011-12-31$1,799,375
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$1,765,641
Value of total corrective distributions2011-12-31$971
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$9,484,638
Value of total assets at end of year2011-12-31$47,641,680
Value of total assets at beginning of year2011-12-31$41,051,902
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$32,763
Total interest from all sources2011-12-31$21,948
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$607,383
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$607,383
Administrative expenses professional fees incurred2011-12-31$5,290
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$5,000,000
If this is an individual account plan, was there a blackout period2011-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2011-12-31$0
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$6,960,477
Participant contributions at end of year2011-12-31$551,189
Participant contributions at beginning of year2011-12-31$524,322
Participant contributions at beginning of year2011-12-31$150
Assets. Other investments not covered elsewhere at end of year2011-12-31$694,119
Assets. Other investments not covered elsewhere at beginning of year2011-12-31$348,680
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$786,779
Value of other receiveables (less allowance for doubtful accounts) at end of year2011-12-31$8,793
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2011-12-31$15,323
Other income not declared elsewhere2011-12-31$-30,076
Administrative expenses (other) incurred2011-12-31$15,123
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$6,589,778
Value of net assets at end of year (total assets less liabilities)2011-12-31$47,641,680
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$41,051,902
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Investment advisory and management fees2011-12-31$12,350
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$30,260,447
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$27,187,175
Interest on participant loans2011-12-31$21,948
Value of interest in common/collective trusts at end of year2011-12-31$16,126,696
Value of interest in common/collective trusts at beginning of year2011-12-31$12,976,252
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-1,535,334
Net investment gain or loss from common/collective trusts2011-12-31$-159,406
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31Yes
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$1,737,382
Employer contributions (assets) at end of year2011-12-31$436
Employer contributions (assets) at beginning of year2011-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$1,765,641
Liabilities. Value of benefit claims payable at beginning of year2011-12-31$0
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31Yes
Opinion of an independent qualified public accountant for this plan2011-12-31Disclaimer
Accountancy firm name2011-12-31MOHLER, NIXON & WILLIAMS
Accountancy firm EIN2011-12-31770106234
2010 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets2010-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$15,040
Total income from all sources (including contributions)2010-12-31$12,400,186
Total loss/gain on sale of assets2010-12-31$0
Total of all expenses incurred2010-12-31$1,712,407
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$1,685,663
Value of total corrective distributions2010-12-31$136
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$7,349,192
Value of total assets at end of year2010-12-31$41,051,902
Value of total assets at beginning of year2010-12-31$30,379,163
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$26,608
Total interest from all sources2010-12-31$22,604
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$307,938
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2010-12-31$307,938
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$5,000,000
If this is an individual account plan, was there a blackout period2010-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2010-12-31$0
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$5,708,451
Participant contributions at end of year2010-12-31$524,322
Participant contributions at beginning of year2010-12-31$487,177
Participant contributions at end of year2010-12-31$150
Participant contributions at beginning of year2010-12-31$116,996
Assets. Other investments not covered elsewhere at end of year2010-12-31$348,680
Assets. Other investments not covered elsewhere at beginning of year2010-12-31$89,543
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$200,381
Value of other receiveables (less allowance for doubtful accounts) at end of year2010-12-31$15,323
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2010-12-31$22,426
Other income not declared elsewhere2010-12-31$24,990
Administrative expenses (other) incurred2010-12-31$9,808
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$10,687,779
Value of net assets at end of year (total assets less liabilities)2010-12-31$41,051,902
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$30,364,123
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Investment advisory and management fees2010-12-31$16,800
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$27,187,175
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$20,328,768
Interest on participant loans2010-12-31$22,604
Value of interest in common/collective trusts at end of year2010-12-31$12,976,252
Value of interest in common/collective trusts at beginning of year2010-12-31$9,307,956
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$3,499,464
Net investment gain or loss from common/collective trusts2010-12-31$1,195,998
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31Yes
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$1,440,360
Employer contributions (assets) at end of year2010-12-31$0
Employer contributions (assets) at beginning of year2010-12-31$26,297
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$1,685,663
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32010-12-31No
Liabilities. Value of benefit claims payable at end of year2010-12-31$0
Liabilities. Value of benefit claims payable at beginning of year2010-12-31$15,040
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31MOHLER, NIXON & WILLIAMS
Accountancy firm EIN2010-12-31770106234
2009 : BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2009-12-31$0

Form 5500 Responses for BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN

2023: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2023 form 5500 responses
2023-01-01Type of plan entitySingle employer plan
2023-01-01Plan funding arrangement – TrustYes
2023-01-01Plan benefit arrangement - TrustYes
2022: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Submission has been amendedNo
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement - TrustYes
2021: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement - TrustYes
2020: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement - TrustYes
2019: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement - TrustYes
2017: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement - TrustYes
2016: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement - TrustYes
2015: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedNo
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes
2012: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2009: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement - TrustYes
2008: BIOMARIN PHARMACEUTICAL INC. RETIREMENT SAVINGS PLAN 2008 form 5500 responses
2008-01-01Type of plan entitySingle employer plan
2008-01-01Submission has been amendedNo
2008-01-01This submission is the final filingNo
2008-01-01This return/report is a short plan year return/report (less than 12 months)No
2008-01-01Plan is a collectively bargained planNo

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
US 401k Lookup     VAT Lookup